Copyright
©The Author(s) 2015.
World J Radiol. Jul 28, 2015; 7(7): 170-179
Published online Jul 28, 2015. doi: 10.4329/wjr.v7.i7.170
Published online Jul 28, 2015. doi: 10.4329/wjr.v7.i7.170
Table 1 Protocol for dynamic perfusion computed tomography acquisition
No. of scans | Cycle time (s) | Accumulated time since start of scan (s) |
3 | 3 | 9 |
9 | 1.5 | 22.5 |
5 | 3 | 37.5 |
5 | 6 | 68.0 |
22 (in total) | Examination time: 68 |
Perfusion parameters | Definition | Unit | Biomarker |
Regional blood flow | Blood flow per unit volume or mass of tissue | mL/100 mL per minute | Tumour vascularization |
Regional tumour blood volume | Ratio of blood volume to tumour volume | mL/100 mL | Tumour vascularization |
Permeability/blood flow extraction (PMB/PS/k-trans) | Rate of transfer of contrast agent from the intravascular to the extravascular compartment | mL/100 gm per minute | Vascular immaturity |
Mean transit time | Average time taken to travel from artery to vein | s | Perfusion pressure |
Time to peak | Time from arrival of the contrast in major arterial vessels to thepeak enhancement | s | Perfusion pressure |
Maximum peak intensity | Maximum increase in tissue density after contrast injection | HU | Tissue blood volume |
Table 3 Perfusion computed tomography parameter values for kidney (renal cell carcinoma vs normal renal cortex)[7]
Normal renal cortex (mean ± SD) | Renal cell carcinoma (mean ± SD) | t value | P value | |
Blood flow (mL/min per 100 g) | 454.32 ± 110.90 | 261.96 ± 175.86 | -7.620 | 0.000 |
Blood volume (mL/100 g) | 23.53 ± 5.71 | 17.17 ± 8.34 | -5.193 | 0.000 |
Mean transit time (s) | 3.62 ± 1.38 | 7.08 ± 3.42 | 7.670 | 0.000 |
Permeability (mL/min per 100 g) | 63.95 ± 18.85 | 25.07 ± 13.20 | -14.193 | 0.000 |
Table 4 Response evaluation using changes in computed tomography perfusion parameters in two representative cases
Date of study | MIP (HU) | TTP (s) | BF (mL/100 mL per minute) | BV (mL/100 mL) | MTT (s) | PMB (mL/100 mL per minute) | ||
Case 1 | 2013-4-2 | Normal cortex | 120 | 11.1 | 202.9 | 31.6 | 8.7 | 47.1 |
Renal tumour | 134 | 13.5 | 184.9 | 30.8 | 10.4 | 45.95 | ||
2013-9-11 | Normal cortex | 121 | 13.2 | 209 | 30.2 | 9.2 | 50.2 | |
Renal tumour | 79 | 11.5 | 174 | 13.2 | 5 | 18.1 | ||
2013-11-20 | Normal cortex | 130 | 10.8 | 229 | 32 | 9.6 | 45.3 | |
Renal tumour | 42 | 12.3 | 5.7 | 1.2 | 12.4 | 8.2 | ||
Case 2 | 2013-10-23 | Normal cortex | 157 | 11.9 | 236 | 27.8 | 8.9 | 43.7 |
Renal tumour | 88 | 12.3 | 64.4 | 9.3 | 8.9 | 18.7 | ||
2013-12-26 | Normal cortex | 140 | 15.2 | 170.9 | 29.5 | 10.5 | 42.1 | |
Renal tumour | 82.7 | 14.8 | 60.9 | 7.9 | 8.4 | 13.8 | ||
2013-8-3 | Normal cortex | 216 | 12.5 | 315 | 38 | 72 | 55.2 | |
Renal tumour | 84.6 | 12.3 | 72.3 | 8 | 7.4 | 10.8 |
Table 5 Comparison of the acquisition parameters and dose in dynamic acquisition of perfusion computed tomography and normal contrast enhanced computed tomography chest and abdomen in our institute
Dynamic acquisition | Chest and abdomenscan (routine) | |
Exposure time (s) | 33 | 14.24 |
Scan length (mm) | 155 | 655 |
Collimation (mm) | 1.2 | 0.6 |
KVp | 100 | 100 |
Ma | 523 | 211 |
CTDI vol (mGy) | 180.1 | 7.2 |
DLP (mGycm) | 2789.69 | 458.68 |
- Citation: Das CJ, Thingujam U, Panda A, Sharma S, Gupta AK. Perfusion computed tomography in renal cell carcinoma. World J Radiol 2015; 7(7): 170-179
- URL: https://www.wjgnet.com/1949-8470/full/v7/i7/170.htm
- DOI: https://dx.doi.org/10.4329/wjr.v7.i7.170